Commentary · 1 Oct 2025
Conference abstractPublished 15 Oct 2013
Type I interferon in human autoimmune disease
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The type I interferon system plays a critical role in host defense in health, and a growing body of literature suggests that type I interferon is a critical mediator of human autoimmune disease. Type I interferons function as a bridge between the innate and adaptive immune systems, and as such plays an important role in setting thresholds for response against self antigens. We have studied type I interferon responses in a number of autoimmune diseases, including systemic lupus erythematosus, dermatomyositis, multiple sclerosis, neuromyelitis optica, and others. In this plenary session, I will summarize our findings and the pathogenic implications of the type I interferon system in human autoimmune disease pathogenesis. Major topics will include how genetic variations impact type I interferon responses in humans, and how activation of this pathway corresponds with particular disease features, providing a window into human disease pathogenesis.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 29 Jan 2018
Chemical Modification of CRISPR gRNAs Eliminate type I Interferon Responses in Human Peripheral Blood Mononuclear Cells
Research article · 2015
Human Pentraxins Bind to Misfolded Proteins and Inhibit Production of Type I Interferon Induced by Nucleic Acid-Containing Amyloid
Commentary · 2021
Assessment of Type I Interferon Signaling in Inflammatory Diseases
Article · 28 May 2025
Type I Interferon Signaling Pathways in Autoimmune Diseases: Mechanisms and Therapeutic Implications
More from this journal
The newest in Journal of Clinical and Cellular Immunology.
Perspective · 10 Sep 2026
Cellular Pathways Involved in Mucosal Immunity and Protection Against Environmental Challenges
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Commentary · 17 Jul 2026
CD5L:p40, a third wheel to IL-12 and IL-23 biology?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Timothy B. Niewold”

